Lisinopril

Product NDC: 64679-941
11-digit product format: 646790941
Labeler code: 64679
Product ID: 64679-941_b760b89e-02b4-8439-e053-2a95a90a9de6
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Lisinopril
Dosage form: TABLET
Route: ORAL
Labeler: Wockhardt USA LLC.
Application: ANDA078402
Marketing category: ANDA
Marketing start: 2007-04-19
Marketing end: 0000-00-00
Substance: LISINOPRIL
Active strength: 20 mg/1
Pharmacologic classes: Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 2021-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 6 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	64679-941		D	Discontinued by firm	2026-08-17
excluded package	package	64679-941	64679-941-01	D	Discontinued by firm	2026-08-17
excluded package	package	64679-941	64679-941-02	D	Discontinued by firm	2026-08-17
excluded package	package	64679-941	64679-941-03	D	Discontinued by firm	2026-08-17
excluded package	package	64679-941	64679-941-05	D	Discontinued by firm	2026-08-17
excluded package	package	64679-941	64679-941-06	D	Discontinued by firm	2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 2 · 90 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	64679-941-02	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	64679-941-01	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	64679-941-03	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	64679-941-06	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	64679-941-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	64679-941-02	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	64679-941-01	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	64679-941-03	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	64679-941-06	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	64679-941-05	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	64679-941-02	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	64679-941-01	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	64679-941-03	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	64679-941-06	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	64679-941-05	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	64679-941-02	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	64679-941-01	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	64679-941-03	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	64679-941-06	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	64679-941-05	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	64679-941-02	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	64679-941-01	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	64679-941-03	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	64679-941-06	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	64679-941-05	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	64679-941-02	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	64679-941-01	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	64679-941-03	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	64679-941-06	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	64679-941-05	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	64679-941-02	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	64679-941-01	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	64679-941-03	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	64679-941-06	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	64679-941-05	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	64679-941-02	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	64679-941-01	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	64679-941-03	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	64679-941-06	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	64679-941-05	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	64679-941-02	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	64679-941-01	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	64679-941-03	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	64679-941-06	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	64679-941-05	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	64679-941-02	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	64679-941-01	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	64679-941-03	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	64679-941-06	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	64679-941-05	`ad56d346431e…`	`cc804d4bbf1e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 6 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A078402-001	LISINOPRIL	LISINOPRIL	2.5MG	TABLET / ORAL	AB	2007-04-19
A078402-002	LISINOPRIL	LISINOPRIL	5MG	TABLET / ORAL	AB	2007-04-19
A078402-003	LISINOPRIL	LISINOPRIL	10MG	TABLET / ORAL	AB	2007-04-19
A078402-004	LISINOPRIL	LISINOPRIL	20MG	TABLET / ORAL	AB	2007-04-19
A078402-005	LISINOPRIL	LISINOPRIL	30MG	TABLET / ORAL	AB	2007-04-19
A078402-006	LISINOPRIL	LISINOPRIL	40MG	TABLET / ORAL	AB	2007-04-19

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 6 matching rows.

Application-product, TE code table
Application-product	TE code
A078402-001	AB
A078402-002	AB
A078402-003	AB
A078402-004	AB
A078402-005	AB
A078402-006	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 7 · 252 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A078402-001	LISINOPRIL	2.5MG	TABLET / ORAL	AB	2007-04-19	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A078402-002	LISINOPRIL	5MG	TABLET / ORAL	AB	2007-04-19	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A078402-003	LISINOPRIL	10MG	TABLET / ORAL	AB	2007-04-19	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A078402-004	LISINOPRIL	20MG	TABLET / ORAL	AB	2007-04-19	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A078402-005	LISINOPRIL	30MG	TABLET / ORAL	AB	2007-04-19	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A078402-006	LISINOPRIL	40MG	TABLET / ORAL	AB	2007-04-19	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A078402-001	LISINOPRIL	2.5MG	TABLET / ORAL	AB	2007-04-19	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A078402-002	LISINOPRIL	5MG	TABLET / ORAL	AB	2007-04-19	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A078402-003	LISINOPRIL	10MG	TABLET / ORAL	AB	2007-04-19	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A078402-004	LISINOPRIL	20MG	TABLET / ORAL	AB	2007-04-19	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A078402-005	LISINOPRIL	30MG	TABLET / ORAL	AB	2007-04-19	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A078402-006	LISINOPRIL	40MG	TABLET / ORAL	AB	2007-04-19	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A078402-001	LISINOPRIL	2.5MG	TABLET / ORAL	AB	2007-04-19	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A078402-002	LISINOPRIL	5MG	TABLET / ORAL	AB	2007-04-19	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A078402-003	LISINOPRIL	10MG	TABLET / ORAL	AB	2007-04-19	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A078402-004	LISINOPRIL	20MG	TABLET / ORAL	AB	2007-04-19	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A078402-005	LISINOPRIL	30MG	TABLET / ORAL	AB	2007-04-19	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A078402-006	LISINOPRIL	40MG	TABLET / ORAL	AB	2007-04-19	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A078402-001	LISINOPRIL	2.5MG	TABLET / ORAL	AB	2007-04-19	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A078402-002	LISINOPRIL	5MG	TABLET / ORAL	AB	2007-04-19	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A078402-003	LISINOPRIL	10MG	TABLET / ORAL	AB	2007-04-19	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A078402-004	LISINOPRIL	20MG	TABLET / ORAL	AB	2007-04-19	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A078402-005	LISINOPRIL	30MG	TABLET / ORAL	AB	2007-04-19	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A078402-006	LISINOPRIL	40MG	TABLET / ORAL	AB	2007-04-19	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A078402-001	LISINOPRIL	2.5MG	TABLET / ORAL	AB	2007-04-19	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A078402-002	LISINOPRIL	5MG	TABLET / ORAL	AB	2007-04-19	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A078402-003	LISINOPRIL	10MG	TABLET / ORAL	AB	2007-04-19	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A078402-004	LISINOPRIL	20MG	TABLET / ORAL	AB	2007-04-19	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A078402-005	LISINOPRIL	30MG	TABLET / ORAL	AB	2007-04-19	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A078402-006	LISINOPRIL	40MG	TABLET / ORAL	AB	2007-04-19	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A078402-001	LISINOPRIL	2.5MG	TABLET / ORAL	AB	2007-04-19	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A078402-002	LISINOPRIL	5MG	TABLET / ORAL	AB	2007-04-19	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A078402-003	LISINOPRIL	10MG	TABLET / ORAL	AB	2007-04-19	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A078402-004	LISINOPRIL	20MG	TABLET / ORAL	AB	2007-04-19	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A078402-005	LISINOPRIL	30MG	TABLET / ORAL	AB	2007-04-19	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A078402-006	LISINOPRIL	40MG	TABLET / ORAL	AB	2007-04-19	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A078402-001	LISINOPRIL	2.5MG	TABLET / ORAL	AB	2007-04-19	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A078402-002	LISINOPRIL	5MG	TABLET / ORAL	AB	2007-04-19	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A078402-003	LISINOPRIL	10MG	TABLET / ORAL	AB	2007-04-19	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A078402-004	LISINOPRIL	20MG	TABLET / ORAL	AB	2007-04-19	`03ed91905a0d…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 7 · 252 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	A078402-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A078402-002	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A078402-003	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A078402-004	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A078402-005	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A078402-006	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A078402-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A078402-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A078402-003	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A078402-004	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A078402-005	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A078402-006	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A078402-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A078402-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A078402-003	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A078402-004	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A078402-005	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A078402-006	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A078402-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A078402-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A078402-003	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A078402-004	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A078402-005	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A078402-006	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A078402-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A078402-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A078402-003	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A078402-004	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A078402-005	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A078402-006	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A078402-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A078402-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A078402-003	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A078402-004	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A078402-005	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A078402-006	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A078402-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A078402-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A078402-003	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A078402-004	AB	1	`03ed91905a0d…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
f8f05a6d-f74b-4e9e-ab1c-374d3b4fb820	Product name	1	20230703
f65307a7-3644-0a09-cdfd-94aae8d3b53e	Product name	3	20210902
1bdb87cf-9b1f-6a51-5eb7-d182aaffaa3d	Product name	2	20170719

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
64679-941-01	2025-12-23	These highlights do not include all the information needed to use LISINOPRIL TABLETS safely and effectively. See full prescribing information for LISINOPRIL TABLETS. LISINOPRIL tablets, for oral use Initial U.S. Approval: 1988
64679-941-02	2025-12-23	These highlights do not include all the information needed to use LISINOPRIL TABLETS safely and effectively. See full prescribing information for LISINOPRIL TABLETS. LISINOPRIL tablets, for oral use Initial U.S. Approval: 1988
64679-941-03	2025-12-23	These highlights do not include all the information needed to use LISINOPRIL TABLETS safely and effectively. See full prescribing information for LISINOPRIL TABLETS. LISINOPRIL tablets, for oral use Initial U.S. Approval: 1988
64679-941-05	2025-12-23	These highlights do not include all the information needed to use LISINOPRIL TABLETS safely and effectively. See full prescribing information for LISINOPRIL TABLETS. LISINOPRIL tablets, for oral use Initial U.S. Approval: 1988
64679-941-06	2025-12-23	These highlights do not include all the information needed to use LISINOPRIL TABLETS safely and effectively. See full prescribing information for LISINOPRIL TABLETS. LISINOPRIL tablets, for oral use Initial U.S. Approval: 1988
64679-941-01	2023-01-30	These highlights do not include all the information needed to use LISINOPRIL TABLETS safely and effectively. See full prescribing information for LISINOPRIL TABLETS. LISINOPRIL tablets, for oral use Initial U.S. Approval: 1988
64679-941-02	2023-01-30	These highlights do not include all the information needed to use LISINOPRIL TABLETS safely and effectively. See full prescribing information for LISINOPRIL TABLETS. LISINOPRIL tablets, for oral use Initial U.S. Approval: 1988
64679-941-03	2023-01-30	These highlights do not include all the information needed to use LISINOPRIL TABLETS safely and effectively. See full prescribing information for LISINOPRIL TABLETS. LISINOPRIL tablets, for oral use Initial U.S. Approval: 1988
64679-941-05	2023-01-30	These highlights do not include all the information needed to use LISINOPRIL TABLETS safely and effectively. See full prescribing information for LISINOPRIL TABLETS. LISINOPRIL tablets, for oral use Initial U.S. Approval: 1988
64679-941-06	2023-01-30	These highlights do not include all the information needed to use LISINOPRIL TABLETS safely and effectively. See full prescribing information for LISINOPRIL TABLETS. LISINOPRIL tablets, for oral use Initial U.S. Approval: 1988

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
64679-941-01	EA - Each	64679-941	0f9ae894-6572-494c-81f9-6154c2991bdd	1	2012-07-24
64679-941-05	EA - Each	64679-941	0f61e9ef-3a35-4a7d-b60a-45bf50337735	1	2012-07-24
64679-941-06	EA - Each	64679-941	59e2f16c-79d2-4f62-8cbe-afbdffd96adc	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
LISINOPRIL	ACTIVE INGREDIENT	E7199S1YWR	LISINOPRIL TABLET, FILM COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	12
LISINOPRIL ANHYDROUS	ACTIVE MOIETY	7Q3P4BS2FD	LISINOPRIL TABLET, FILM COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	12
BROWN IRON OXIDE	INACTIVE INGREDIENT	1N032N7MFO	LISINOPRIL TABLET, FILM COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	12
CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE	INACTIVE INGREDIENT	O7TSZ97GEP	LISINOPRIL TABLET, FILM COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	12
CORN STARCH 3-E-DODECENYL SUCCINIC ANHYDRIDE MODIFIED	INACTIVE INGREDIENT	QG4MW19XYX	LISINOPRIL TABLET, FILM COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	12
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	LISINOPRIL TABLET, FILM COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	12
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	LISINOPRIL TABLET, FILM COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	12
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	LISINOPRIL TABLET, FILM COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	12
MANNITOL	INACTIVE INGREDIENT	3OWL53L36A	LISINOPRIL TABLET, FILM COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	12
POVIDONES	INACTIVE INGREDIENT	FZ989GH94E	LISINOPRIL TABLET, FILM COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	12
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	LISINOPRIL TABLET, FILM COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	12
LISINOPRIL	ACTIVE INGREDIENT	E7199S1YWR	LISINOPRIL TABLET LISINOPRIL TABLET [STAT RX USA LLC]	2
LISINOPRIL ANHYDROUS	ACTIVE MOIETY	7Q3P4BS2FD	LISINOPRIL TABLET LISINOPRIL TABLET [STAT RX USA LLC]	2
BROWN IRON OXIDE	INACTIVE INGREDIENT	1N032N7MFO	LISINOPRIL TABLET LISINOPRIL TABLET [STAT RX USA LLC]	2
DIBASIC CALCIUM PHOSPHATE DIHYDRATE	INACTIVE INGREDIENT	O7TSZ97GEP	LISINOPRIL TABLET LISINOPRIL TABLET [STAT RX USA LLC]	2
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	LISINOPRIL TABLET LISINOPRIL TABLET [STAT RX USA LLC]	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	LISINOPRIL TABLET LISINOPRIL TABLET [STAT RX USA LLC]	2
MANNITOL	INACTIVE INGREDIENT	3OWL53L36A	LISINOPRIL TABLET LISINOPRIL TABLET [STAT RX USA LLC]	2
POVIDONE	INACTIVE INGREDIENT	FZ989GH94E	LISINOPRIL TABLET LISINOPRIL TABLET [STAT RX USA LLC]	2
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	LISINOPRIL TABLET LISINOPRIL TABLET [STAT RX USA LLC]	2
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	LISINOPRIL TABLET LISINOPRIL TABLET [STAT RX USA LLC]	2
LISINOPRIL	ACTIVE INGREDIENT	E7199S1YWR	LISINOPRIL TABLET [WOCKHARDT USA LLC.]	1
LISINOPRIL	ACTIVE MOIETY	E7199S1YWR	LISINOPRIL TABLET [WOCKHARDT USA LLC.]	1
BROWN IRON OXIDE	INACTIVE INGREDIENT	1N032N7MFO	LISINOPRIL TABLET [WOCKHARDT USA LLC.]	1
DIBASIC CALCIUM PHOSPHATE DIHYDRATE	INACTIVE INGREDIENT	O7TSZ97GEP	LISINOPRIL TABLET [WOCKHARDT USA LLC.]	1
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	LISINOPRIL TABLET [WOCKHARDT USA LLC.]	1
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	LISINOPRIL TABLET [WOCKHARDT USA LLC.]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	LISINOPRIL TABLET [WOCKHARDT USA LLC.]	1
MANNITOL	INACTIVE INGREDIENT	3OWL53L36A	LISINOPRIL TABLET [WOCKHARDT USA LLC.]	1
POVIDONE	INACTIVE INGREDIENT	FZ989GH94E	LISINOPRIL TABLET [WOCKHARDT USA LLC.]	1
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	LISINOPRIL TABLET [WOCKHARDT USA LLC.]	1
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	LISINOPRIL TABLET [WOCKHARDT USA LLC.]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
64679-941	LISINOPRIL TABLET [WOCKHARDT USA LLC.]	5	Legacy NDC	20201227_e927801e-5de4-44f9-b543-789c093de655.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
E7199S1YWR	LISINOPRIL	83915-83-7	LISINOPRIL

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
314077	lisinopril 20 MG Oral Tablet	PSN	da181889-6cb1-4521-a959-08112c82eb3b	2
197884	lisinopril 40 MG Oral Tablet	PSN	da181889-6cb1-4521-a959-08112c82eb3b	2
314077	lisinopril 20 MG Oral Tablet	SCD	da181889-6cb1-4521-a959-08112c82eb3b	2
197884	lisinopril 40 MG Oral Tablet	SCD	da181889-6cb1-4521-a959-08112c82eb3b	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
64679-941-01	64679094101	100 TABLET in 1 BOTTLE (64679-941-01)	100 tablet	2007-04-19	0000-00-00	No	No	Current
64679-941-02	64679094102	3000 TABLET in 1 BOTTLE (64679-941-02)	3000 tablet	2007-04-19	0000-00-00	No	No	Current
64679-941-03	64679094103	10 BLISTER PACK in 1 CARTON (64679-941-03) > 10 TABLET in 1 BLISTER PACK	10 blister pack	2007-04-19	0000-00-00	No	No	Current
64679-941-05	64679094105	500 TABLET in 1 BOTTLE (64679-941-05)	500 tablet	2007-04-19	0000-00-00	No	No	Current
64679-941-06	64679094106	1000 TABLET in 1 BOTTLE (64679-941-06)	1000 tablet	2007-04-19	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Lisinopril	Wockhardt USA LLC. \| Atlantide Pharmaceuticals AG \| Wockhardt Limited	2020-12-26	HUMAN PRESCRIPTION DRUG LABEL	5
Lisinopril Tablets	NCS HealthCare of KY, Inc dba Vangard Labs	2013-02-25	HUMAN PRESCRIPTION DRUG LABEL	12
Lisinopril Tablets USP	STAT Rx USA LLC \| PSS World Medical Inc	2012-10-01	HUMAN PRESCRIPTION DRUG LABEL	2